EV/EBITDA:
-5.23-0.06(-1.16%)Summary
- As of today (June 29, 2025), NAMS EV/EBITDA is -5.23, with a fall of -0.06 (-1.16%) during the most recent trading session on June 27, 2025.
- Over the past year, NAMS EV/EBITDA has increased by +1.39 (+21.00%).
- NAMS EV/EBITDA is now -59.45% below its all-time high of -3.28.
Performance
NAMS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NAMS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.2% | +1.0% | +0.7% |
| 1 m1 month | -15.2% | +15.1% | +9.2% |
| 3 m3 months | +25.3% | -20.9% | -17.1% |
| 6 m6 months | +60.4% | -43.9% | -28.2% |
| ytdytd | +37.1% | -33.4% | -27.7% |
| 1 y1 year | +21.0% | +4.7% | -5.0% |
| 5 y5 years | - | - | - |
NAMS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -4.54 | -15.2% | -6.66 | +21.5% |
| 3 m | 3-month | -3.61 | -44.9% | -7.00 | +25.3% |
| 6 m | 6-month | -3.61 | -44.9% | -13.19 | +60.4% |
| 1 y | 1-year | -3.61 | -44.9% | -13.39 | +60.9% |
| 3 y | 3-year | -3.28 | -59.5% | -13.39 | +60.9% |
| 5 y | 5-year | -3.28 | -59.5% | -13.39 | +60.9% |
| alltime | all time | -3.28 | -59.5% | -13.39 | +60.9% |
NAMS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -5.23(-37.1%) |
| Date | Value |
|---|---|
| 2024 | -8.31(+153.4%) |
| 2023 | -3.28 |
FAQ
- What is NewAmsterdam Pharma Company NV EV/EBITDA?
- What is the all time high EV/EBITDA for NewAmsterdam Pharma Company NV?
- What is NAMS EV/EBITDA year-to-date change?
- What is NewAmsterdam Pharma Company NV EV/EBITDA year-on-year change?
What is NewAmsterdam Pharma Company NV EV/EBITDA?
The current EV/EBITDA of NAMS is -5.23
What is the all time high EV/EBITDA for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high EV/EBITDA is -3.28
What is NAMS EV/EBITDA year-to-date change?
NewAmsterdam Pharma Company NV EV/EBITDA has changed by +3.08 (+37.06%) since the beginning of the year
What is NewAmsterdam Pharma Company NV EV/EBITDA year-on-year change?
Over the past year, NAMS EV/EBITDA has changed by +1.39 (+21.00%)